SCHEMBL27968487

SCHEMBL27968487

NCc1cccc(-c2ccc(Cc3ccccc3)s2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2E1 P05181 3/20 0.62
CYP3A4 P08684 3/20 0.62
CYP2A6 P11509 3/20 0.62
CYP2C9 P11712 3/20 0.62
CYP2B6 P20813 3/20 0.62
CYP2C19 P33261 3/20 0.62
LOXL2 Q9Y4K0 2/20 0.44
CYP2D6 P10635 2/20 0.43
TAAR1 Q96RJ0 1/20 0.43
RORC P51449 1/20 0.42
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
KLKB1 P03952 1/20 0.41
KLK1 P06870 1/20 0.41
TRPV1 Q8NER1 1/20 0.40
CFD P00746 2/20 0.40
HPGDS O60760 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C8 P10632 1/20 0.40
ADORA2A P29274 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27968335 0.89 CYP2E1 (0.62) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL5972875 0.87 CYP2A6 (0.62) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL27634496 0.82 KLK1 (0.43) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL27968345 0.81 CYP3A4 (0.49) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL27968341 0.81 HSD17B1 (0.51) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL2690207 0.77 CYP2E1 (1.00) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
Hydrochloric Acid SCHEMBL31558446 0.76 CYP2A6 (0.96) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL25155424 0.76 PRMT6 (0.57) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL4316965 0.76 APP (0.53) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6
SCHEMBL1692333 0.76 SMN1; SMN2 (0.49) CYP2E1CYP3A4CYP2A6CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103214471-B The preparation method of compound with Na-dependent glucose transporter inhibitory activity 田边三菱制药株式会社 2018-02-06 CN disclosed
CN-104109155-A Novel compounds TANABE SEIYAKU CO 2014-10-22 CN disclosed
CN-103819465-A Novel compound MITSUBISHI TANABE PHARMA CORP 2014-05-28 CN disclosed